Accordingly, some evidence for SCLC-transformation occurring more rapidly in EGFRM+ than in EGFR-wt LACs has been provided, though after transformation survival and response to platinum-etoposide appear similar in the two groups and resemble those in conventional SCLC [199]. Here, EGFR is linked to small cell lung carcinoma.